Makoto Okabe
Directeur/Bestuurslid bij NORITAKE CO., LIMITED
Profiel
Makoto Okabe is currently a Director & Senior Managing Executive Officer at Noritake Co., Ltd.
since 2023.
Prior to this, Mr. Okabe was a Director at ImmunoFrontier, Inc.
Actieve functies van Makoto Okabe
| Bedrijven | Functie | Begin |
|---|---|---|
| NORITAKE CO., LIMITED | Directeur/Bestuurslid | 23-06-2023 |
Eerdere bekende functies van Makoto Okabe
| Bedrijven | Functie | Einde |
|---|---|---|
ImmunoFrontier, Inc.
 ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NORITAKE CO., LIMITED | Producer Manufacturing |
| Bedrijven in privébezit | 1 |
|---|---|
ImmunoFrontier, Inc.
ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | Commercial Services |